In small cell lung cancer (SCLC), the protein DLL3 is a promising target in the development of emerging therapies. In ...
Hospitals are places of survival, but for those living with sickle cell disease, they can also feel like theatres of power where the patient is both actor and captive. Every admission is a negotiation ...